Clinical Trials
- HIV/AIDS, Hepatitis, Infectious Disease, Immune System
Screening In Anticipation of Future Research
- Ages2 years - 17 years
- GenderBoth
- Date10/25/2017
- Liver, Hepatitis
Digoxin In Alcohol Associated Hepatitis
- Ages21 years - 65 years
- GenderBoth
- Date10/12/2021
- Hepatitis
An Observational Study of Patients Undergoing Therapy for Chronic Hepatitis B (HBV) Infection
- Ages18 years and older
- GenderBoth
- Date01/31/2019
- Genetics
Efficacy and Safety of WTX101 Administered for 48 Weeks Versus Standard of Care in Wilson Disease Subjects
- Ages12 years and older
- GenderBoth
- Date04/02/2018
- Liver
A Phase 2b Study in Subjects With Alcoholic Hepatitis to Evaluate Safety and Efficacy of DUR-928 Treatment (AHFIRM)
- Ages18 years and older
- GenderBoth
- Date11/02/2021
- Liver
Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA) (MIRNA)
- Ages18 years - 75 years
- GenderBoth
- Date01/08/2021
- Liver
A Study to Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASH (VOYAGE)
- Ages18 years - 75 years
- GenderBoth
- Date07/19/2021
- Digestive System, Liver
Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) (ELATIVE)
- Ages18 years - 75 years
- GenderBoth
- Date12/03/2021
- Immune System
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)
- Ages18 years - 75 years
- GenderBoth
- Date07/27/2021
- Genetics, Endocrine System
A Phase I/II Study of VTX-801 in Adult Patients With Wilson's Disease (GATEWAY)
- Ages18 years - 60 years
- GenderBoth
- Date08/01/2021